114 related articles for article (PubMed ID: 38523410)
1. Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway.
Wang X; Liu H; Wang Y; Wang P; Yi Y; Lin Y; Li X
J Gastroenterol Hepatol; 2024 Mar; ():. PubMed ID: 38523410
[TBL] [Abstract][Full Text] [Related]
2. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY; Ding Q; Li Z; Zhang CQ
Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
[TBL] [Abstract][Full Text] [Related]
3. Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathway.
Ji D; Zhao Q; Qin Y; Tong H; Wang Q; Yu M; Mao C; Lu T; Qiu J; Jiang C
Cell Biol Int; 2021 Sep; 45(9):1866-1875. PubMed ID: 33835632
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.
Lei Y; Wang QL; Shen L; Tao YY; Liu CH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):575-584. PubMed ID: 30857885
[TBL] [Abstract][Full Text] [Related]
5. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
6. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 attenuates CCl4 Induced Liver Fibrosis by Inhibiting Autophagy-Mediated HSC activation
Li J; Deng X; Wang S; Jiang Q; Xu K
Front Pharmacol; 2021; 12():792414. PubMed ID: 34987404
[TBL] [Abstract][Full Text] [Related]
8. P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Xue R; Zhou J; Wu J; Meng Q; Gong J; Shen L
Dig Dis Sci; 2023 Apr; 68(4):1339-1350. PubMed ID: 36002675
[TBL] [Abstract][Full Text] [Related]
9. Ethyl Acetate Fraction of Dicliptera chinensis (L.) Juss. Ameliorates Liver Fibrosis by Inducing Autophagy via PI3K/AKT/mTOR/p70S6K Signaling Pathway.
Liu Y; Bi YM; Pan T; Zeng T; Mo C; Sun B; Gao L; Lyu ZP
Chin J Integr Med; 2022 Jan; 28(1):60-68. PubMed ID: 34105096
[TBL] [Abstract][Full Text] [Related]
10. C6orf120 gene deficiency may be vulnerable to carbon tetrachloride induced acute hepatic injury in rats.
Zhang J; Zhang MK; Ma HM; Song XC; Wu YN; Zhang R; He LL; Ye XH; Gao MX; Li X
Arch Med Sci; 2022; 18(6):1626-1637. PubMed ID: 36457959
[TBL] [Abstract][Full Text] [Related]
11. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
[TBL] [Abstract][Full Text] [Related]
12. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.
Wang A; Bu FT; Li JJ; Zhang YF; Jia PC; You HM; Wu S; Wu YY; Zhu S; Huang C; Li J
Toxicol Lett; 2022 Feb; 355():88-99. PubMed ID: 34838997
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits the activity and induces apoptosis of activated hepatic stellate cell by suppressing autophagy.
Shu Y; He Y; Ye G; Liu X; Huang J; Zhang Q; Tian D; Wang T; Shu J
J Cell Biochem; 2023 Nov; 124(11):1764-1778. PubMed ID: 37909649
[TBL] [Abstract][Full Text] [Related]
15. [Hydroxynitone suppresses hepatic stellate cell activation by inhibiting TGF-β1 phosphorylation to alleviate CCl
Zhao Z; Dong H; Li B; Shen B; Guo Y; Gu T; Qu Y; Cai X; Lu L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1511-1516. PubMed ID: 36329585
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid A attenuates CCl
Wang R; Song F; Li S; Wu B; Gu Y; Yuan Y
Drug Des Devel Ther; 2019; 13():1889-1900. PubMed ID: 31213776
[No Abstract] [Full Text] [Related]
18. The Therapeutic Mechanisms of Propolis Against CCl
Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
[TBL] [Abstract][Full Text] [Related]
19. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.
Liu QW; Ying YM; Zhou JX; Zhang WJ; Liu ZX; Jia BB; Gu HC; Zhao CY; Guan XH; Deng KY; Xin HB
Stem Cell Res Ther; 2022 Jun; 13(1):224. PubMed ID: 35659360
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
